Logo image of CHEK

CHECK CAP LTD (CHEK) Stock Fundamental Analysis

NASDAQ:CHEK - Nasdaq - IL0011336851 - Common Stock - Currency: USD

0.8172  0 (-0.1%)

Fundamental Rating

2

Overall CHEK gets a fundamental rating of 2 out of 10. We evaluated CHEK against 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for CHEK as it has an excellent financial health rating, but there are worries on the profitability. CHEK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CHEK has reported negative net income.
In the past year CHEK has reported a negative cash flow from operations.
In the past 5 years CHEK always reported negative net income.
CHEK had a negative operating cash flow in each of the past 5 years.
CHEK Yearly Net Income VS EBIT VS OCF VS FCFCHEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

CHEK's Return On Assets of -97.11% is on the low side compared to the rest of the industry. CHEK is outperformed by 79.79% of its industry peers.
CHEK has a Return On Equity of -102.28%. This is in the lower half of the industry: CHEK underperforms 62.77% of its industry peers.
Industry RankSector Rank
ROA -97.11%
ROE -102.28%
ROIC N/A
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
CHEK Yearly ROA, ROE, ROICCHEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

CHEK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHEK Yearly Profit, Operating, Gross MarginsCHEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, CHEK has about the same amount of shares outstanding.
CHEK has more shares outstanding than it did 5 years ago.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHEK Yearly Shares OutstandingCHEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
CHEK Yearly Total Debt VS Total AssetsCHEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

CHEK has an Altman-Z score of -10.69. This is a bad value and indicates that CHEK is not financially healthy and even has some risk of bankruptcy.
CHEK's Altman-Z score of -10.69 is on the low side compared to the rest of the industry. CHEK is outperformed by 80.85% of its industry peers.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.69
ROIC/WACCN/A
WACCN/A
CHEK Yearly LT Debt VS Equity VS FCFCHEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 19.66 indicates that CHEK has no problem at all paying its short term obligations.
CHEK's Current ratio of 19.66 is amongst the best of the industry. CHEK outperforms 98.94% of its industry peers.
CHEK has a Quick Ratio of 19.66. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
CHEK has a Quick ratio of 19.66. This is amongst the best in the industry. CHEK outperforms 98.94% of its industry peers.
Industry RankSector Rank
Current Ratio 19.66
Quick Ratio 19.66
CHEK Yearly Current Assets VS Current LiabilitesCHEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

CHEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.87%, which is quite good.
EPS 1Y (TTM)10.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CHEK will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.32% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHEK Yearly EPS VS EstimatesCHEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CHEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHEK Price Earnings VS Forward Price EarningsCHEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHEK Per share dataCHEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as CHEK's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHECK CAP LTD

NASDAQ:CHEK (5/30/2025, 8:00:00 PM)

0.8172

0 (-0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners2.52%
Inst Owner Change-31.81%
Ins Owners6.24%
Ins Owner ChangeN/A
Market Cap4.78M
Analysts43.33
Price TargetN/A
Short Float %1.1%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.28
EV/EBITDA N/A
EPS(TTM)-3
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)-2.4
OCFYN/A
SpS0
BVpS2.94
TBVpS2.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -97.11%
ROE -102.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.66
Quick Ratio 19.66
Altman-Z -10.69
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)214.2%
Cap/Depr(5y)207.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.58%
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.22%
OCF growth 3YN/A
OCF growth 5YN/A